A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models - Concepedia

Concepedia

Publication | Closed Access

A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models

41

Citations

41

References

2004

Year

Stuart L. Emanuel, Robert H. Gruninger, Angel R. Fuentes‐Pesquera, Peter J. Connolly, Jennifer A. Seamon, Susan Hazel, Rose Tominovich, Beth Hollister, Cheryl Napier, Michael R. D’Andrea,

Molecular Pharmacology

References

	Year	Citations

Page 1